Related Experiment Video
Updated: Nov 28, 2025

Assessment of Waste-Derived Biochars on the Health and Biological Activity of Soil
Published on: October 10, 2025
Can charcoal improve outcomes in COVID-19 infections?
Zeid J Khitan1, Imran Khawaja1, Maurice A Mufson1
1Joan C. Edwards School of Medicine, Marshall University, United States.
Abstract:
COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Controls in Experiments
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pneumonia II: Pathophysiology
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

